Pura Vida Investments’s Lombard Medical, Inc. EVAR Stock Holding History

Pura Vida Investments’s Portfolio EVAR Stock Details EVAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-52,875	Closed	-$189K	–	93
2015 Q3	$189K	Hold	52,875	–	–	0.11%	64
2015 Q2	$216K	Hold	52,875	–	–	0.11%	66
2015 Q1	$213K	Sell	52,875 -283,150	-84%	-$1.46M	0.11%	62
2014 Q4	$2.18M	Buy	+336,025	New	+$2.2M	0.8%	45

Other funds holding EVAR

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.1% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

WMSA

Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Pura Vida Investments's EVAR Position: Q4 2015 in Review

Pura Vida Investments sold out of Lombard Medical, Inc. (EVAR) in Q4 2015, closing a stake of 52,875 shares — an estimated $189K sold.

Pura Vida Investments first reported a position in EVAR in Q4 2014 and held it in 4 quarters. The position peaked at $2.18M in Q4 2014. 18 funds tracked by Wall St. Rank hold EVAR as of Q4 2015.

Pura Vida Investments reported no remaining Lombard Medical, Inc. position as of Q4 2015 after selling out during the quarter.
Pura Vida Investments sold 52,875 Lombard Medical, Inc. shares in Q4 2015, an estimated $189K.
Pura Vida Investments first reported a position in Lombard Medical, Inc. in Q4 2014 and held it in 4 quarters.
Pura Vida Investments's Lombard Medical, Inc. position peaked at $2.18M in Q4 2014.
18 funds tracked by Wall St. Rank held Lombard Medical, Inc. as of Q4 2015.

Based on Pura Vida Investments's 13F filing for Q4 2015, filed 16 Feb 2016.